Home
About
Overview
Sharing Data
ORCID
Help
History (210)
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study.
Catalytic mechanism of endonuclease v: a catalytic and regulatory two-metal model.
Interleukin-12
Copper-catalyzed ortho-acylation of phenols with aryl aldehydes and its application in one-step preparation of xanthones.
Outcomes and complications associated with off-label and untested use of drug-eluting stents.
See All 210 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcomes and complications associated with off-label and untested use of drug-eluting stents.
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
View in:
PubMed
subject areas
Aged
Angioplasty, Balloon, Coronary
Consumer Product Safety
Female
Hospital Mortality
Humans
Immunosuppressive Agents
Male
Middle Aged
Paclitaxel
Platelet Aggregation Inhibitors
Prospective Studies
Registries
Risk
Sirolimus
Stents
Survival Analysis
Ticlopidine
Treatment Outcome
United States
authors with profiles
Charles Lee Bennett